Literatúra a zdroje informácií, ktoré sme použili na našich stránkach
Publikácie a Internet

Všeobecný zdroj informácií o hubách:
Gothárd, Cs. – Taracközi, I. 2021 GYÓGYÍTÓ GOMBÁK MYCOTHERAPIA, DRTV Média Plus Kft., Budapest
Autor uvedenej knihy, Dr. Csaba Gothárd (lekár, lektor, učiteľ a liečiteľ) sa podieľal aj na vývoji a formulácii väčšiny našich tekutých výťažkov z húb.

Trúdnikovec pestrý:
Benedix EH, et al. 1977 Növényvilág. Alacsonyabbrendű növények. Gondolat Kiadó, Budapest.
Chang R. 1996 Functional properties of edible mushrooms. Nutr. Rev. Nov; 54 (11 Pt 2): S91-3Dureja H, Kaushik Kumar V. 2003 Developments in Nutraceuticals.Indian Journal of Pharmacology, 35:363-372.
Hobbs Ch. 1995 Medicinal Mushrooms. An Exploration of Tradition, Healing, & Culture. Botanica Press, Santa Cruz, Ca, USA.
Jakucs Erzsébet – Hahn István 1995 Mi a gomba?…..in: Járainé Komlódi Magda: Pannon Enciklopédia. Magyarország Növényvilága.-99. Dunakanyar 2000 Kiadó, Budapest.
Jakucs Erzsébet, Vajna László (szerk.) 2003 Mikológia. Agroinform Kiadó, Budapest.
Jones PJ. 2002 Clinical nutrition. 7. Functional foods – more than just nutrition. CMAJ June 11, 166 (12): 1555-1563.
Kalra EK. 2003 Nutraceutical – Definition and Introduction. AAPS PharmSci 5(3) Article 25 (https://www.pharmsci.org)
Kidd Parris M. 2000 The Use of Mushroom Glucans and Proteoglycans in Cancer Treatment. Alternative Medicine Review Volume 5, Number 1, 4-27.
Lelley J. 1999 A gombák gyógyító ereje. Mezőgazda Kiadó, Budapest.
Leung Albert Y, Foster S 1 Encyclopedia of Common Natural Ingredients. John Wiley & Sons Inc., New York – Chichester – Brisbane -Toronto – Singapore.
Lewis Walter H, Elvin-Lewis PF 1977 Medical Botany. John Wiley & Sons., Inc., New York – London – Sydney -Toronto.
Monroe JA. 2003 Treatment of cancer with mushroom products.
Sheng-Yuang Wang, Mind-Shi Shao 2000 Pharmacological Functions of Chinese Medicinal Fungus Cordyceps sinensis and Related Species. Journal of Food and Drug Analysis 8(4): 248-257.
Silva D. 2004 Cellular and physiological effects of Ganoderma lucidum. Mini Rev Med Chem. Oct;4(8):873-9.
Simon Tibor (szerk.) 1991 Baktérium- alga-, gomba-, zuzmó- és mohahatározó. Nemzeti Tankönyvkiadó, Budapest.
Smith JE, Sullivan R. 2004 The western approach to medicinal mushrooms. https://www.kmitl.ac.th/science/journal/jan2004/Mushrooms.pdf
Stamets P. 1993 Growing Gourmet & Medicinal Mushrooms. Ten Speed Press, Berkeley, CA, USA.
Stamets P. 2002 MycoMedicinals. An informational Treatise on Mushrooms. MycoMedia Productions, Olimoia, WA, USA.
Stamets P. Novel Antimicrobials from mushrooms. 2002 Herbalgram 54: 28-33.
Wang Sheng-Yuan, Shiao Ming-Shi 2000 Pharmacological Functions of Chinese Medicinal Fungus Cordyceps sinensis and Related Species. Journal of Food and Drug Analysis. Vol. 8. No. 4. 248-257.
Wasser SP, Weis AL. 1999 Therapeutic effects of substances occuring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol. 19(1):65-96.
Wasser SP. 2002 Medicinal mushrooms as a source of antitumor and immunmodulating polysaccharides. Appl.Microbiol Biotechnol. 60:258-274. Wasser SP.
2002 Review of Medicinal Mushrooms Advances: Good News from Old Allies. Herbalgram 56:28-33.
Wasser SP, Didukh MYa 2004 Dietary Supplements from Culinary-Medicinal Mushrooms: A Variety of Regulations and Safety Concers for the 21st Century, Intl. Journal of Medicinal Mushr., Volumes 3.
Zaidman BZ, Yassin M, Mahajna J, Wasser SP. Medicinal mushroom modulators of molecular targets as cancer therapeutics.
Zhong JJ, Tang YJ. 2004 Submerged cultivation of medicinal mushrooms for production of valuable bioactive metabolites. Adv Biochem Eng Biotechnol. 87:25-59.

Hliva ustricová:
https://egeszsegter.hu/cikk/1124/laskagomba-a-gyogyito-gomba
VETTER, J (1999): A laskagomba (Pleurotus ostreatus) beltartalmáról. A MAGYAR ZÖLDSÉG-GYÜMÖLCS TERMÉKTANÁCS GOMBA TAGOZATÁNAK LAPJA 3 (11) 21- 23. p.World J. Fungal & Plant Biol., 3 (1): 01-12, 2012.

Lesklokôrovka lesklá:
Berger A, et al. 2004 Cholesterol-lowering properties of Ganoderma lucidum in vitro, ex vivo, and in hamsters and in minipigs. Lipids in Health Disease 3, 1-12.
.https://www.gyogynoveny-volgy.com/gyogygombak/pecsetviaszgomba
Klinické skúšky: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0224740
BAO, X.-F., LIU, C., FANG, J., LI, X. (2001): Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohydrate Research, 332 67-74. p.
BAO X.-F., WANG, X.-S., DONG, Q., FANG, J., LI, X. (2002): Structural features of immunologically active polysaccharides from Ganoderma lucidum. Phytochemistry, 59 175- 181. p. 110
BYONG KAK KIM (2004): Medicinal Efficacies of Ganoderma lucidum (XV) Anti-HIV Activities of Ganoderma lucidum.
GRABBE, K. (1997): A gombák helye az emberi táplálkozásban. Magyar Gombahíradó, 16 6-7. p.
HOBBS, C. (1995): Medicinal Mushrooms. Botancia Press, Santa Cruz, California.
HUIE, C.W., DI, X. (2004): Chomatographic and electrophoretic methods for Linghzing pharmacologically active components. Journal of Chromatography, 812 241-257. p.
IGMÁNDY, Z. (1970): Magyarország taplógombái. II. rész. Mikológiai Közlemények, 3 109-112. p.
JAKUCS E. (2003): Gyógyító gombáink. A MAGYAR ZÖLDSÉG- GYÜMÖLCS TERMÉKTANÁCS GOMBA TAGOZAT LAPJA 7 (19) 10-14. p. 112JAKUCS E., VAJNA, L. (2003): Mikológia. Agroinform Kiadó és Nyomda Kft, Budapest.
LELLEY, J. (1999): A gombák gyógyító ereje. Mezőgazda Kiadó, Budapest 49. LELLEY, J. (2008): Die Heilkraft der Pilze, Wer Pilze isst lebt langer. B.O.S.S. Druck und Medien GmbH, Goch.
SARAH B. MANNING, TINA E., FLECHER, CH. (2000): Medicinal mushrooms: Food for Thought, Mushroom News, 2 20-23. p.
SEO, G.S., KIRK, P.M. (2000): Ganodermataceae: Nomenclature and Classification. Ganoderma Diases of Perennial Crops. Cabi Publishing, Cab International, Wallingford Oxon OX10 8DE, United Kingdom. 1-267. p.
STAMETS, P. (1993): Growing Gourmet and Medicinal Mushrooms, First Edition, Ten Speed Press, Berkeley, Toronto.

Koralovec ježovitý:
Kupperman Menopausa Index (KMI), mely a változókori tünetek (hőhullám, verítékezés, alvászavar, idegesség, szédülés, koncentrációs képesség, ízületi panaszok, fejfájás, szívdobogásérzés) súlyosságának megítélésére szolgál.
Center for Epidemiological Study – Depression Scale (CES-D), mely a depresszió, azaz a rossz hangulat (érdeklődés elvesztése, örömtelenség, reményvesztettség) súlyosságának megítélésére szolgál.
Pittsburgh Sleep Quality Index (PSQI), azaz az alvás minőség index, melynek segítségével meghatározhatjuk az alvásprobléma súlyosságát.
Indefinite Complaints Index (ICI), azaz a határozatlan panaszok indexe, mint például a bőrszárazság, a hüvely, a hólyag, a szem, a bélrendszer állapotának megítélése, a hajritkulás fokának meghatározása stb.
http://www.ncbi.nlm.nih.gov/pubmed/23557368
http://www.ncbi.nlm.nih.gov/pubmed/3932005
http://www.ncbi.nlm.nih.gov/pubmed/18844328
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176599/
http://www.ncbi.nlm.nih.gov/pubmed/20834180
http://www.ncbi.nlm.nih.gov/pubmed/18844328
http://www.ncbi.nlm.nih.gov/pubmed/24631140
http://www.ncbi.nlm.nih.gov/pubmed/23668749
https://www.ncbi.nlm.nih.gov/pubmed/23557368
https://www.ncbi.nlm.nih.gov/pubmed/24906751
https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZHNK509.010.htm
https://en.cnki.com.cn/Article_en/CJFDTOTAL-ZGYZ200920020.htm
Prof. Dr. Michaela Döll: Vitalpilze für ein gesundes Leben, Herbig Verlag, 2012, 63-66.
Klinické skúšky:
https://www.ncbi.nlm.nih.gov/pubmed/20834180
https://www.ncbi.nlm.nih.gov/pubmed/18844328
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3176599/

Trsovnica lupeňovitá:
Prof. Dr. Michaela Döll: Vitalpilze für ein gesundes Leben, Herbig Verlag, 2012, 58-62.
Klinické skúšky:
https://www.ncbi.nlm.nih.gov/pubmed/14977447
https://www.ncbi.nlm.nih.gov/pubmed/12499658
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0224740
https://www.ncbi.nlm.nih.gov/pubmed/14977447
https://www.ncbi.nlm.nih.gov/pubmed/12499658
https://www.ncbi.nlm.nih.gov/pubmed/15706424
https://www.ncbi.nlm.nih.gov/pubmed/20563803
https://www.ncbi.nlm.nih.gov/pubmed/17089056
https://www.ncbi.nlm.nih.gov/pubmed/17131118

Hliva kotúčová:
Szarvas, J., Naár, Z., Geösel, A., Győrfi J. (2010): In vitro investigation of King Oyster Mushroom [Pleurotus eryngii (DC.: Fr.) Quél.] strains in vegetative growing phases. International Journal of Horticultural Science, 16 (2): 47-53.
Szarvas, J., Geösel, A., Pál, K., Naár, Z., Győrfi, J. (2011): Comparative studies of the cultivable king oyster mushroom [Pleurotus eryngii (DC.: Fr.) Quél.] isolates by RAPD-PCR method. Acta Alimentaria, 40 (Suppl.), 214-221.
SZARVAS, J. & SZARVAS, G. (2002): Az ördögszekér laskagomba (Pleurotus eryngii) termesztése. Magyar Gombahíradó, 10 (36): 6-7
VETTER, J. (2010): A gombák gyógyhatásai – gyógygombák. In: Győrfi Júlia (szerk.), Gombabiológia, gombatermesztés. Mezőgazda Kiadó, Budapest, pp. 64-77.

Húževnatec jedlý:
Molitoris, H. P.: „Mushrooms in Medicine”, Folia Microbiol. 39,91-98 (1994).
Klinické skúšky: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0224740
American Cancer Society: „Shiitake mushroom”, http://www.cancer.org.
Chihara G., Hamuro J., Maeda Y., Shiio T., Suga T., Takasuka. N., Sasaki T.: „Antitumor and metastasis-inhibitary activities of lentinan as an immunmodulator: an overview”, Cancer Detect. Prev. Suppl., 1987; 1:423-443.
Memorial Sloan Kettering Cancer Center: "Shiitake mushroom", http://www.mskcc.org/mskcc/html/69377.cfm
Kurtzman, R. H.: „Mushrooms: sources for modern western medicine” Micol. Aplicda Int., 2005, 17(2): 21-33.
Lindegnist. U., Timo, H. j., Niedermeyer, J., Jülich, W-D.: „The pharmacological potential of mushrooms”, eCAM 2005, 2: 285-299.
Yap A. T., Ng, M. L.: „Immunopotentiating properties of lentinan (1-3)- β-D-glucan extracted from culinary-medicinal Shiitake mushroom Lentinus edodes (Berk.)” , Int. j. Med. Mushrooms, 2003; 5: 339-358.
Bisen P.S. Baghel R.K., Sanodiya B. S.: „Lentinus edodes: a macrofungus with pharmacological activities”, Curr. Med. Chem., 2010; 17(22): 2419-2430.
Chan, G. C. F., Chan, W. K., and Sze, D. M. Y. :” The effects of β-glucan on human immune and cancer cells.” Journal of Hematology and Oncology, 2009; 2:25–33.
Driscoll M, Hansen R, Ding C, Cramer DE, Yan J.: „ Therpeutic potencial of various βglucan sources in conjunction with antitumor monoclonal antibody in cancer therapy.” Cancer Biology& Therapy, 2009; 8(3):218-225.
Fang, N., Li, Q., Yu, S.: „ Inhibition of growth and induction of apoptosis in human cancer cell lines by an ethyl acetate fraction from shiitake mushrooms.” , Journal of Alternative & Complementary Medicine, 2006; 12(2):125-132
Hearst, R., Nelson, D., McCollum, G.: „An examination of antibacterial and antifungal properties of constituents ofShiitake
(Lentinula edodes) and oyster (Pleurotus ostreatus) mushrooms.” Complementary Therapies in Clinical
Practice, 2009; 15(1):57.
Martin, K. R. and Brophy, S. K:.” Commonly consumed and specialty dietary mushrooms reduce cellular proliferation in MCF7 human breast cancer cells.” Experimental Biology and Medicine 235(11):1306-1314.
Rao, J. R.,Smyth,T. J., Millar, B.C.: „ Antimicrobial properties of shiitake mushrooms (Lentinula edodes).”, International Journal of Antimicrobial Agents, 2009; 33(6):591-592.
Rop O(1), Mlcek J, Jurikova T.: „Beta-glucans in higher fungi and their health effects.”, Nutr Rev. 2009, 67(11):624-631.
Sasidharan S., Aravindran S., Latha L.Y.: „In Vitro Antioxidant Activityand Hepatoprotective Effects of Lentinula edodes aganis paracetamol-induced hepatotoxicity”, Molecules, 2010; 23: 4478-4489.
Ina K(1), Kataoka T, Ando T.: „The use of lentinan for treating gastric cancer.”, Anticancer Agents Med. Chem., 2013; 13(5):681-688.
Memorial Sloan-Kettering Cancer Center: „Lentinan”, http://www.mskcc.org/cancer-care/herb/lentinan, 2013
Cancer Research UK: "Mushrooms and cancer", http://www.cancerresearchuk.org/about-cancer/cancers-in-general/cancer- questions/mushrooms-in-cancer-treatment ; 2013
Lo, H. C., and S. P. Wasser: "Medicinal Mushrooms for Glycemic Control in Diabetes Mellitus”, Int J Med Mushrooms.2011;13(5):401-426.
National Cancer Institute: "Shiitake", http://www.cancer.gov/dictionary?cdrid=285741
Yu-ling Shi, Anthony E. James, Iris F. F. Benzie, and John A. Buswell.: „Genoprotective Activity of Edible and Medicinal Mushroom Components.”, Int. J. Med. Mushrooms, 2004; 6:1-14.
Mizuno, T. : „ The extraction and development of antitumour active polysaccharides from medicinal mushrooms in Japan.” Int. J. Med. Mushrooms. 1:9–30.
Badalyan SM. : „Antiprotozoal activity and mitogenic effect of mycelium of culinary-medicinal shiitake mushroom Lentinus edodes (Berk.)”, Int. J. Med. Mushrooms, 2004; 6:131-138.
Brandt, C. R. and F. Piraino.: „ Mushroom antivirals.”, Recent Res. Dev. Antimicrob. Agents Chemother., 2000; 4: 11–26.
https://www.vitalitas-magazin.hu/belgyogyaszat/immunerosito-rakgyogyito-shiitake-gomba
CHANG, SHU-TING (2000): Production of cultivated edible mushroom in China with emphasis on Lentinula edodes. https://www. hri.ac.uk/isms/article6.htm.
CHIHARA, G. (1993): Medical aspects of lentinan isolated from Lentinus edodes (Berk.) Sing. In: Mushroom biology and mushroom products. The Chinese University Press, Hong Kong.. 261-226. p.
VETTER, J (2001): A shiitake gomba (Lentinula edodes) beltartalmáról. A MAGYAR ZÖLDSÉG-GYÜMÖLCS TERMÉKTANÁCS GOMBA TAGOZATÁNAK LAPJA 5 (17) 25- 28. p.